Clinical and molecular analysis of NF-κB essential modulator in Chinese incontinentia pigmenti patients

International Journal of Dermatology

Volumn 46, Issue 10, 2007, Pages 1017-1022

  Zou, Chao Chun ^a   Zhao, Zheng Yan ^a  

^a CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE GAMMA; MELANIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; ECTODERMAL DYSPLASIA; EXON; FAMILY HISTORY; FEMALE; GENE DELETION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; INCONTINENTIA PIGMENTI; INFANT; INTRON; MALE; MUTATIONAL ANALYSIS; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PREVALENCE; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; HETEROZYGOTE; HUMANS; I-KAPPA B KINASE; INCONTINENTIA PIGMENTI; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SKIN;

EID: 34848859956     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03365.x     Document Type: Article

References (19)

1. Carney RG. Incontinentia pigmenti. A world statistical analysis. Arch Dermatol 1976; 112: 535-542.
2. Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet 1993; 30: 53-59.
3. Hadj-Rabia S, Froidevaux D, Bodak N, et al. Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol 2003; 139: 1163-1170.
4. Fusco F, Bardaro T, Fimiani G, et al. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-κB activation. Hum Mol Genet 2004; 13: 1763-1773.
5. Steffann J, Raclin V, Smahi A, et al. A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti. Prenat Diagn 2004; 24: 384-388.
6. Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000; 405: 466-472.
7. Aradhya S, Woffendin H, Jakins T, et al. A recurrent deletion in the ubiquitously expressed NEMO (IKK -γ) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet 2001; 10: 2171-2179.
8. Mercurio F, Murray BW, Shevchenko A, et al. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol 1999; 19: 1526-1538.
9. Isräel A. The IKK complex: An integrator of all signals that activate NF-κB? Trends Cell Biol 2000; 10: 129-133.
10. Yamaoka S, Courtois G, Bessia C, et al. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 1998; 93: 1231-1240.
11. Parrish JE, Scheuerle E, Lewis RA, et al. Selection against mutant alleles in blood leukocytes is a consistent feature in incontinentia pigmenti type 2. Hum Mol Genet 1996; 5: 1777-1783.
12. Bardaro T, Falco G, Sparago A, et al. Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKγ dene deletion. Hum Mutat 2003; 21: 8-11.
13. Bruckner AL. Incontinentia pigmenti. a window to the role of NF-κB function. Semin Cutan Med Surg 2004; 23: 116-124.
14. Jean-Baptiste S, O'Toole EA, Chen M, et al. Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti. Clin Exp Immunol 2002; 127: 470-478.
15. Kasmann-Kellner B, Jurin-Bunte B, Ruprecht KW. Incontinentia pigmenti (Bloch-Sulzberger-syndrome): Case report and differential diagnosis to related dermato-ocular syndromes. Ophthalmologica 1999; 213: 63-69.
16. Rothwarf DW, Zandi E, Natli G, et al. IKK-γ is an essential regularly subunit of IκB kinase complex. Nature 1998; 395: 297-300.
17. Nenci A, Huth M, Funteh A, et al. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum Mol Genet 2006; 15: 531-542.
18. Bonif M, Meuwis MA, Close P, et al. TNFα- and IKKβ-mediated TANK/I-TRAF phosphorylation: Implications for interaction with NEMO/ IKKγ and NF-κB activation. Biochem J 2006; 394: 593-603.
19. Orstavik KH, Kristiansen M, Knudsen GP, et al. Novel splicing mutation in the NEMO (IKK-γ) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation. Am J Med Genet A 2006; 140: 31-39.